Axsome Therapeutics Inc. (NASDAQ: AXSM) received FDA clearance for its neurological candidate last week, causing the company’s stock to rise by more than 60% in
Edgio Inc. (NASDAQ: EGIO), a provider of content distribution systems, announced revenue growth that was above Wall Street’s expectations. The announcement boosted the company’s stock
According to last week’s second-quarter results, advertising income at music provider Spotify Technology SA (NYSE: SPOT) is fast expanding and will likely be a primary
Instructure Inc. (NYSE: INST), a software business, has announced agreements with significant IT and educational technology companies. At the auction on July 14, INST quotations
DexCom Inc. (NASDAQ: DXCM), a provider of mobile continuous glucose monitoring systems, is extending its solution offering and working to bring its devices to the
Shares of video streaming hardware and software provider Roku Inc. (NASDAQ: ROKU) hit $101.88 in trading on June 8. The reason for this was rumors
Abercrombie & Fitch Co.’s (NYSE: ANF) prices were up more than 16 percent to $22.23 in May 25 trade. This helped to counterbalance the approximately
Brookfield Infrastructure Partners LP (NYSE: BIP), a miscellaneous owner, recently stated the rising importance of natural gas and expanded investment in this attractive sector. Natural
Tryp Therapeutics Inc (OTC: TRYPF) surged up 35.48% to $0.063 at yesterday’s close after progress in the clinical trials of its lead candidate. The volume
Sweetgreen Inc. (NYSE: SG) is a fast-food restaurant franchise that went public at the end of last year. The prices have retraced over 50 percent
At baxterreport.com, we aim to keep investors informed about both the long-term and short-term performance of the market. Comparatively, we have a unique approach to stock market news. The focus of our research is on the fundamentals of smaller and less popular stocks, with an emphasis on pre, post, and intraday trades.
Content on our website is designed to be easily read, understood, and simple to follow. Regardless of your level of expertise, you should still be able to figure it out. Baxterreport.com simplify content in order to make complex issues understandable for beginners. We analyze stocks based on the available financial data and do not have any financial stakes in any of the companies we cover. We strive to cover all matters fairly and accurately, without favoritism or criticism for financial gain.
Contact us: info@baxterreport.com
